Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia (Q46945614)

26 December 2017

title

Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia (English)

1 reference

26 December 2017

0 references

Ann Marie Schmidt

1 reference

26 December 2017

author name string

Paola Pichiule

series ordinal

1 reference

26 December 2017

Juan Carlos Chavez

series ordinal

1 reference

26 December 2017

Susan J Vannucci

series ordinal

1 reference

26 December 2017

language of work or name

English

0 references

publication date

17 October 2007

1 reference

26 December 2017

Journal of Biological Chemistry

published in

1 reference

26 December 2017

volume

282

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

36330-36340

1 reference

26 December 2017

The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

S100B potently activates p65/c-Rel transcriptional complexes in hippocampal neurons: Clinical implications for the role of S100B in excitotoxic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Autocrine S100B effects on astrocytes are mediated via RAGE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Receptor for Advanced Glycation End Products Activation Injures Primary Sensory Neurons via Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

RAGE is expressed in pyramidal cells of the hippocampus following moderate hypoxic-ischemic brain injury in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Understanding hypoxia signalling in cells--a new therapeutic opportunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemia in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Diabetes, leukoencephalopathy and rage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Experimental stroke in the female diabetic, db/db, mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Estrogen stimulates microglia and brain recovery from hypoxia-ischemia in normoglycemic but not diabetic female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

The transcriptional activator hypoxia inducible factor 2 (HIF-2/EPAS-1) regulates the oxygen-dependent expression of erythropoietin in cortical astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

S100B binding to RAGE in microglia stimulates COX-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Structural and functional insights into RAGE activation by multimeric S100B

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M706407200

21 January 2018

Identifiers

DOI

10.1074/JBC.M706407200

1 reference

26 December 2017

1 reference

26 December 2017